Fisher Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $38.4M | Buy |
|
|||||
|
2024
Q4 | $42.9M | Buy |
|
|||||
|
2024
Q3 | $36.4M | Buy |
|
|||||
|
2024
Q2 | $37.8M | Sell |
|
|||||
|
2024
Q1 | $50M | Sell |
|
|||||
|
2023
Q4 | $44.1M | Sell |
|
|||||
|
2023
Q3 | $37M | Sell |
|
|||||
|
2023
Q2 | $42.5M | Sell |
|
|||||
|
2023
Q1 | $43.6M | Sell |
|
|||||
|
2022
Q4 | $54.7M | Buy |
|
|||||
|
2022
Q3 | $47.4M | Sell |
|
|||||
|
2022
Q2 | $54.1M | Buy |
|
|||||
|
2022
Q1 | $70.5M | Sell |
|
|||||
|
2021
Q4 | $94.8M | Buy |
|
|||||
|
2021
Q3 | $100M | Buy |
|
|||||
|
2021
Q2 | $87M | Sell |
|
|||||
|
2021
Q1 | $69M | Sell |
|
|||||
|
2020
Q4 | $60.4M | Sell |
|
|||||
|
2020
Q3 | $56.6M | Sell |
|
|||||
|
2020
Q2 | $47.4M | Sell |
|
|||||
|
2020
Q1 | $37.1M | Sell |
|
|||||
|
2019
Q4 | $53.1M | Sell |
|
|||||
|
2019
Q3 | $58M | Sell |
|
|||||
|
2019
Q2 | $66.9M | Buy |
|
|||||
|
2019
Q1 | $64.1M | Buy |
|
|||||
|
2018
Q4 | $49.3M | Buy |
|
|||||
|
2018
Q3 | $51M | Buy |
|
|||||
|
2018
Q2 | $40.9M | Sell |
|
|||||
|
2018
Q1 | $40.4M | Sell |
|
|||||
|
2017
Q4 | $47.7M | Sell |
|
|||||
|
2017
Q3 | $48.8M | Sell |
|
|||||
|
2017
Q2 | $46.3M | Sell |
|
|||||
|
2017
Q1 | $41.7M | Sell |
|
|||||
|
2016
Q4 | $37.3M | Sell |
|
|||||
|
2016
Q3 | $42.4M | Sell |
|
|||||
|
2016
Q2 | $44.2M | Sell |
|
|||||
|
2016
Q1 | $42.6M | Buy |
|
|||||
|
2015
Q4 | $41.5M | Buy |
|
|||||
|
2015
Q3 | $30.7M | Sell |
|
|||||
|
2015
Q2 | $35.8M | Buy |
|
|||||
|
2015
Q1 | $31.9M | Buy |
|
|||||
|
2014
Q4 | $24.4M | Buy |
|
|||||
|
2014
Q3 | $22M | Sell |
|
|||||
|
2014
Q2 | $19.9M | Buy |
|
|||||
|
2014
Q1 | $12.7M | Buy |
|
|||||
|
2013
Q4 | $2.88M | Buy |
|
|||||
|
2013
Q3 | $2.42M | Buy |
|